About Omeprazole API
Therapeutic CategoryGastro-Intestinal - GI
API Technology
Synthetic
Dose Form
Oral Solid/Tablets
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Korea DMF
Mechanism of Action
Omeprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the gastric mucosa, omeprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.
Indication
PRILOSEC is a proton pump inhibitor (PPI) indicated for the:
- Treatment of active duodenal ulcer in adults
- Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults
- Treatment of active benign gastric ulcer in adults
- Treatment of symptomatic gastroesophageal reflux disease (GERD) in patients 1 year of age and older
- Treatment of erosive esophagitis (EE) due to acid-mediated GERD in patients 1 month of age and older
- Maintenance of healing of EE due to acid-mediated GERD in patients 1 year of age and older
- Pathologic hypersecretory conditions in adults
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
FAQs
Treats GERD, gastric and duodenal ulcers, erosive esophagitis, and Zollinger-Ellison syndrome
Reduces stomach acid production
Alleviates heartburn and acid reflux
Promotes healing of esophageal and stomach lining
GERD: 20 mg once daily
Gastric Ulcer: 40 mg once daily
Duodenal Ulcer: 20 mg once daily
Store at 20°C to 25°C (68°F to 77°F), protect from moisture and light
Descargo de responsabilidad
Ninguna información en este sitio web, incluyendo cualquier referencia a cualquier producto o servicio, constituye una oferta de venta ni se interpretará como tal. Los productos protegidos por patentes válidas no se ofrecen ni suministran para uso comercial. Sin embargo, en ciertos casos, a discreción exclusiva de Dr. Reddy's y sujeto a los requisitos legales locales, las cantidades de investigación de dichos productos pueden ofrecerse para fines de presentaciones regulatorias según la Sección 107A de la Ley de Patentes de la India (exención de Bolar), donde existan dichas exenciones regulatorias. Los compradores deben realizar su propia evaluación del producto o servicio, incluyendo el escenario de patentes en sus respectivos mercados, y serán responsables de todas las responsabilidades relacionadas con las patentes. Dr. Reddy's renuncia a todas las garantías, expresas o implícitas, incluyendo, entre otras, las garantías de comerciabilidad, idoneidad para un propósito particular y no infracción.